Personalized immunoglobulin aptamers for detection of multiple myeloma minimal residual disease in serum
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2399-3642
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Personalized immunoglobulin aptamers for detection of multiple myeloma minimal residual disease in serum ; volume:3 ; number:1 ; day:17 ; month:12 ; year:2020 ; pages:1-12 ; date:12.2020
Communications biology ; 3, Heft 1 (17.12.2020), 1-12, 12.2020
- Urheber
-
Tapia-Alveal, Claudia
Olsen, Timothy R.
Worgall, Tilla S.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s42003-020-01515-x
- URN
-
urn:nbn:de:101:1-2021011819181827196663
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tapia-Alveal, Claudia
- Olsen, Timothy R.
- Worgall, Tilla S.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Multiple myeloma immunoglobulin lambda translocations portend poor prognosis
Minimal residual disease in multiple myeloma: current status
In vitro selection and characterization of DNA aptamers against a multiple myeloma monoclonal protein
Widespread amyloidogenicity potential of multiple myeloma patient-derived immunoglobulin light chains
Measurable residual disease in multiple myeloma: ready for clinical practice?
Stability of split-aptamers
Phenotypic detection of clonotypic B cells in multiple myeloma by specific Immunoglobulin ligands reveals their rarity in multiple myeloma
Broadly applicable TCR-based therapy for multiple myeloma targeting the immunoglobulin J chain
Paraneoplastic Filiform Hyperkeratosis and Immunoglobulin-Associated Vasculitis in Myeloma Progression: A Case Report
The deubiquitinase OTUD1 regulates immunoglobulin production and proteasome inhibitor sensitivity in multiple myeloma
Minimal Residual Disease Assessment in the Context of Multiple Myeloma Treatment
Colorimetric Aptasensor of Vitamin D3: A Novel Approach to Eliminate Residual Adhesion between Aptamers and Gold Nanoparticles
Multiple myeloma immunoglobulin lambda translocations portend poor prognosis
Minimal residual disease in multiple myeloma: current status
In vitro selection and characterization of DNA aptamers against a multiple myeloma monoclonal protein
Widespread amyloidogenicity potential of multiple myeloma patient-derived immunoglobulin light chains
Measurable residual disease in multiple myeloma: ready for clinical practice?
Stability of split-aptamers
Phenotypic detection of clonotypic B cells in multiple myeloma by specific Immunoglobulin ligands reveals their rarity in multiple myeloma
Broadly applicable TCR-based therapy for multiple myeloma targeting the immunoglobulin J chain
Paraneoplastic Filiform Hyperkeratosis and Immunoglobulin-Associated Vasculitis in Myeloma Progression: A Case Report
The deubiquitinase OTUD1 regulates immunoglobulin production and proteasome inhibitor sensitivity in multiple myeloma
Minimal Residual Disease Assessment in the Context of Multiple Myeloma Treatment
Colorimetric Aptasensor of Vitamin D3: A Novel Approach to Eliminate Residual Adhesion between Aptamers and Gold Nanoparticles
Multiple myeloma immunoglobulin lambda translocations portend poor prognosis
Minimal residual disease in multiple myeloma: current status
In vitro selection and characterization of DNA aptamers against a multiple myeloma monoclonal protein
Widespread amyloidogenicity potential of multiple myeloma patient-derived immunoglobulin light chains
Measurable residual disease in multiple myeloma: ready for clinical practice?
Stability of split-aptamers
Phenotypic detection of clonotypic B cells in multiple myeloma by specific Immunoglobulin ligands reveals their rarity in multiple myeloma
Broadly applicable TCR-based therapy for multiple myeloma targeting the immunoglobulin J chain
Paraneoplastic Filiform Hyperkeratosis and Immunoglobulin-Associated Vasculitis in Myeloma Progression: A Case Report
The deubiquitinase OTUD1 regulates immunoglobulin production and proteasome inhibitor sensitivity in multiple myeloma
Minimal Residual Disease Assessment in the Context of Multiple Myeloma Treatment